Laurence Turka

Laurence Turka

Corporate Officer/Principal en
Immune Tolerance Network
.
68 años
Commercial Services
Health Technology
Consumer Services

Perfil

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Cargos activos de Laurence Turka

EmpresasCargoInicio
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/1995
Corporate Officer/Principal 01/01/2003

Antiguos cargos conocidos de Laurence Turka.

EmpresasCargoFin
RUBIUS THERAPEUTICS Director Técnico/Científico/I+D 31/01/2023
Fundador 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Presidente -
Ver el detalle de la experiencia de Laurence Turka.

Formación de Laurence Turka.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

49

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Commercial Services

Health Technology

Government

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology